Concluding Thoughts on the Evolving World of Global Regulatory Affairs
| Intended Reader Biopharma leaders | Key Takeaways Striking a Balance Between Speed and Safety Global Collaboration for Effective Regulatory Pathways Agile Regulations for Rapidly